GlassScriptPhysician profile
John J Depowell
NPI 1467663757
$14,616.71
in general payments reported to CMS, 2019-2025
7 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,444 · 2020: $92.75 · 2021: $2,917 · 2022: $1,613 · 2023: $1,755 · 2024: $3,586 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,340 · Food and Beverage: $1,190 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,340.00 |
| Food and Beverage | $1,189.53 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,738.29 | 2021-2025 | Elevate Spinal System, Midas Rex, Unid_pass |
| Medtronic USA, INC. | $4,367.26 | 2019-2020 | |
| Icotec Medical INC. | $299.03 | 2024-2025 | Icotec Blackarmor Spine System, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Stryker Corporation | $110.02 | 2019 | |
| Depuy Synthes Sales INC. | $59.39 | 2020 | |
| Zimmer Biomet Holdings, INC. | $22.72 | 2023 | Ti Rapidflap Spindown |
| Csl Behring | $20.00 | 2024 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Depowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.